Sensorion selects new drug for disorders with inner ear lesions

Friday, Sep 30, 2016

Sensorion selects new drug candidate, SENS-401, to treat vestibular and auditory disorders associated with inner ear lesions.

SENS-401 will also strengthen sensorion's intellectual property portfolio, and company has filed new patent applications to seek commercial exclusivity for SENS-401 until 2036.

Sensorion has decided to select SENS-401, instead of 218, as its final drug candidate for treating lesions of inner ear.


Source :

Other News